{
  "schema_version": "1.3.1",
  "doc": {
    "doc_id": "932086a6929bda1e5e50ac369606cc16",
    "title": "Jefferies",
    "source_uri": "2025-08-29/On Clients Minds - JapanOn Clients Minds - Japan_2025-08-29",
    "language": "en",
    "timestamps": {
      "ingested_at": "2025-10-27T00:43:34.824210",
      "extracted_at": "2025-10-27T00:43:34.824217"
    },
    "extraction_run": {
      "vision_model": "deepseek-ai/DeepSeek-OCR",
      "synthesis_model": "rule-based-engine",
      "pipeline_steps": [
        "ocr",
        "rule_extraction",
        "figure_vision"
      ],
      "processing_metadata": {
        "pages_processed": 9,
        "successful_pages": 9,
        "date": "2025-08-29",
        "publication": "2025-08-29",
        "authors": [],
        "markdown_cleaning": {
          "removed_sections": 2,
          "removed_paragraphs": 6,
          "reduction_ratio": 0.2564145611237024
        },
        "input_relative_path": "2025-08-29"
      }
    }
  },
  "passages": [
    {
      "passage_id": "2d73cfa07f260e99",
      "text": "Japan | Japan Insights",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "82b7e1aed41ed60e",
      "text": "On Clients' Minds - Japan",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "d2d76d3aac026ab0",
      "text": "We are pleased to present a selection of research from Japan and across the world that was of the greatest interest to readers over the past week. These include select top- down pieces, stock and sector research.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "5f466d31433e9a67",
      "text": "Japan Quantitative Strategy Japan's 2025 AGM season saw a record 53 shareholder proposals in the Topix 100 universe, up sharply from 11 in 2024 (and 22/6 in 2023/22), signaling a bold new era of investor activism. Proposals focused on governance, board composition, environmental issues, and performance- linked compensation policies. We highlight companies where support for management- backed board and chairman nominations declined, potentially signaling structural change ahead.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "fdfc26a89316f066",
      "text": "Chugai Chugai's ADR climbed \\(2\\%\\) and shares in Lilly rose almost \\(6\\%\\) (S&P500 up \\(0.4\\%\\) ) after Lilly announced new Orforglipron data in obesity patients with diabetes. The headline \\(10.5\\%\\) weight reduction at the highest dose is lower than the \\(12.4\\%\\) observed in a non- diabetic patients (report). We consider this data to be broadly in line with investor expectations, because diabetic patients typically lose less weight than non- diabetic patients.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "6bfca122c6b8604a",
      "text": "Japan Tech According to Chinese import statistics announced this week, Jul Chinese SPE imports were \\(\\) 503.6bn\\((+12\\%YoY,+12\\%MoM)\\). Imports for Jan- Jul total\\) \\ \\(28.141bn(+2\\%)\\) As Jan- Jul imports were stronger than expected, deceleration is expected from Aug onward. Taiwan SPE imports in Jul were \\(\\) 3.210bn(+42\\%)\\), showing continued strong growth YOY. Within this, imports from Malaysia (including SoC testers from Advantest) were \\(\\) 581mn\\(down slightly vs. Jun, but still high.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "cb0fdc00d74d4419",
      "text": "Terumo We slightly raise our current and future estimates to take account of strong 1Q results (report), and the company's planned \\(\\) 1.5bn\\(acquisition of organ technology company, OrganOx. We reiterate our\\) \\ \\(3,300\\) PT, and since this represents \\(26\\%\\) potential upside, we reiterate Buy.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "b9bceb2b72deccca",
      "text": "Japan IT Services We update our earnings estimates for ILJ, Otsuka, Trend Micro and SCSK, and upgrading ILJ from Hold to Buy, raising our PT from \\(\\) 3,000\\(to\\) \\ \\(3,600\\) . ILJ has been trading at a discount to the result of our coverage due to the VMware and cyber security incidents. Market demand for network integration remains steady. We cut our PT for Trend Micro and raise our PTs for Otsuka and SCSK, but maintain our ratings for these three stocks.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "6e77c335043695f9",
      "text": "Japan SaaS We are upgrading Rakus from Hold to Buy as the company targets to deliver on the 'Rule of 50', which looks realistic. We are also raising our PT for Money Forward from \\(\\) 6,000\\(to\\) \\ \\(8,000\\) . Free, we maintain Buy but cut our PT from \\(\\) 5,000\\(to\\) \\ \\(4,100\\) . Our top in the sector remaining Money Forward, followed by Rakus and free.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "52ef27b307bb89b7",
      "text": "UABJ We update our earnings forecasts for UACJ post Q1 FY3/26 earnings (link). We raise off PT to \\(\\) 6,300\\(, as we expect earnings upside from margins widening between US aluminum prices vs. UBC costs, and ASP hikes should also support profits in Japan. However, given the steep rally in the share price, we think the upside is limited, and hence downgrade the stock to Hold. Potential risks include trade tariffs, cross- shareholding unwinds, and equity issuance.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "566ee8182b22407c",
      "text": "Nabtesco Mgmt continues evaluating the operating efficiency and growth story of existing business units. Mgmt aims to achieve FY27 sales targets for disclosed major segments, and its comment led us to believe the scale of any near- term reorganization action may be smaller than the announced divestiture of hydraulic equipment business. Our new price target implies Nabtesco's profit growth over FY25- 26 has been reflected in consensus estimates.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "9fa04bebb08cf776",
      "text": "US Insights: What You Need to Know",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "5bdae0cb8ec4990a",
      "text": "Europe Insights: In Case You Missed It...",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "2e69126e55c51408",
      "text": "On Clients' Minds - Asia",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "6a498b70b53692d3",
      "text": "Japan Business & Employment Services We update our models for Persol and En Japan and retain Hold rating. This sector has been active in M&A, with the latest instance being Technopro (6028 JP), which is in talks for a takeover by Blackstone. As for En Japan, Hong Kong- based activist fund Oasis has declared \\(6\\%\\) stake in April 2025. Therefore, other companies may follow a similar pattern, in our view. As for the Q1 and outlook, Persol has room to increase earnings in Q3, after a likely lukewarm Q2.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "e1d0684c871c2cf2",
      "text": "Ulvac Ulvac announced FY6/25 results on Aug13. It reported \\(\\yen 26.5bn\\) in FY6/25 OP (- 11% YoY), roughly in line with guidance updated at 3Q timing. Ulvac officially announced the Value Up Plan, a new longer- term business plan that covers five years. It presented detailed content of the plan to implement business reforms over the next two years and accelerate growth through FY6/31. We revise our estimates. Revise PT to \\(\\yen 8,000\\) . Maintain Buy rating.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "a4b365aecbcf4d24",
      "text": "Aurelia Metals uEBITDA was broadly in line with our and VAE when accounting for \\(\\) 7.85\\(mn non- recurring biodiversity credits sales. Lower D&A was partially offset by higher interest expense. Planned FY26 debt refi will unlock liquidity, while Fed's shift to commercial production will normalise the P&L and commence depreciating. Ramp - up at Fed, and growth at Peak & Great Cobar is clouded by lingering Resource uncertainty at Fed. Reiterate BUY, PT AUD0.28.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "387d4162dbf2c2b5",
      "text": "Franchise Report: India Pharmaceuticals India's CRDMO industry is at an inflection point, evolving from quasi- chemical firms to strategic partners for innovators, backed by capabilities and geographic diversification. We believe China+1 is a structural story that can drive high- teen revenue CAGR for the next decade. Our pipeline analysis reveals a healthy molecules buildup for Sai, Piramal, Divi's and Cohanee. We initiate coverage on Cohanee with Buy, upgrade Divi's to Buy, and our top pick is Sai.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "41a282369a383773",
      "text": "China Tech US President Trump's offer to lift the ban on H20 to entice China to relax rare earth export controls has backfired, as China has already banned H20 purchases \"until further notice.\" The \"chip for rare earth\" strategy failed. But China is likely more interested in \"rare earths for WFE,\" as its LT plan is to make its own AI chips to avoid getting \"addicted\" to US tech. China's chip imports still exceed its oil imports. Western WFE stocks could benefit.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "c3cbf35f2c8c0d14",
      "text": "USA Thematic Research Jefferies hosted over 100 companies at the 2025 Consumer Conference this past week. Many of the individual discussions were recapped in greater detail in separate notes. High- level takeaways include: 1) stable but continued pressure on the low- end consumer; 2) a focus on execution & self- help mindset an uncertain macro and 3) mgmt. teams incorporating plenty of tariff policy cushion outloots.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "afe58f923ea83442",
      "text": "USA Software Software adoption is accelerating in the enterprise but remains early, with monetization still in the low to mid- single digit range of overall revenue. We expect a broader ramp into 2026, with MSFT (top enterprise pick), META (top consumer pick), & SNOW (data & AI breakout play) among the best- positioned to capitalize on this shift, offering attractive risk/reward as AI moves from hype to tangible rev impact. See \\(175+\\) pg deep dive inside.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "14cd62a7c85ce868",
      "text": "Uranks Pre- GFC, over \\(6\\%\\) of housing changed hands each year. Today, that is \\(4\\%\\) . Stamp duty, where marginal rates can reach \\(15\\%\\) , likely plays a role, impeding mobility and the efficient use of stock. Reduced churn also traps housing equity, now the largest pool of UK household wealth. Given the fiscal challenges, reform of housing taxes may be a risk too far. But as a demand and supply side policy, there may be few with as much potential.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "18b94c5e9105fc5e",
      "text": "Europe Chemicals The majority of the European chemicals coverage require an above average 2H earnings contribution to reach guidance/consensus forecasts. We are on average \\(- 2\\%\\) below consensus (- 4% across diversifies, and - 1% in consumer chemicals), whilst consumer ingredients",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "213c7eabcab7881a",
      "text": "For Important Disclosure information on companies recommended in this report, please visit our website at https://javatar.bluematrix.com/ sellside/Disclosures.action or call 212.284.2300.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "a912eb0405c3829a",
      "text": "(Article 3(1)e and Article 7 of MAR)",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "c165feec6c8944bd",
      "text": "Recommendation Published Recommendation Distributed",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "448e6c048ed426ef",
      "text": "August 29, 2025 3:40 A.M. August 29, 2025 4:00 A.M.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "2c52894a07e12c24",
      "text": "James Heaney has a long position in Facebook.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "dfb648aa6f311320",
      "text": "Within the past twelve months, Jefferies Financial Group Inc. and/or its affiliates received compensation for products and services other than investment banking services from non- investment banking, securities related compensation for client services it provided to Microsoft Corporation.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "397497c705f48293",
      "text": "Within the past twelve months, SAI Life Sciences Ltd has been a client of Jefferies Financial Group Inc., its affiliates or subsidiaries and investment banking services are being or have been provided.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "36a5d9f9f5975de7",
      "text": "Jefferies International Ltd, its affiliates or subsidiaries has, or had, within the past 12 months an agreement to provide investment services to SAI Life Sciences Ltd.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "12c39cc2b4c33f36",
      "text": "Jefferies Financial Group Inc., its affiliates or subsidiaries has acted as a manager or co- manager in the underwriting or placement of securities for SAI Life Sciences Ltd or one of its affiliates within the past twelve months.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "492a9905a28f6bbc",
      "text": "Within the past 12 months, Jefferies Financial Group Inc., its affiliates or subsidiaries has received compensation from investment banking services from SAI Life Sciences Ltd.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "e26e64c5eed79444",
      "text": "For Important Disclosure information on companies recommended in this report, please visit our website at https://javatar.bluematrix.com/ sellside/Disclosures.action or call 212.284.2300.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "8ce97b4caa791a82",
      "text": "Buy - Describes securities that we expect to provide a total return (price appreciation plus yield) of \\(15\\%\\) or more within a 12- month period. Hold - Describes securities that we expect to provide a total return (price appreciation plus yield) of plus \\(15\\%\\) or minus \\(10\\%\\) within a 12- month period. Underperform - Describes securities that we expect to provide a total return (price appreciation plus yield) of minus \\(10\\%\\) or less within a 12- month period. The expected total return (price appreciation plus yield) for Buy rated securities with an average security price consistently below \\(10\\) is \\(20\\%\\) or more within a 12- month period as these companies are typically more volatile than the overall stock market. For Hold rated securities with an average security price consistently below \\(10\\) , the expected total return (price appreciation plus yield) is plus or minus \\(20\\%\\) within a 12- month period. For Underperform rated securities with an average security price consistently below \\(10\\) , the expected total return (price appreciation plus yield) is minus \\(20\\%\\) or less within a 12- month period.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "cb9a4bbb50036857",
      "text": "NR - The investment rating and price target have been temporarily suspended. Such suspensions are in compliance with applicable regulations and/or Jefferies policies.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "ad7677ea1dc08d6e",
      "text": "CS - Coverage Suspended. Jefferies has suspended coverage of this company.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "8a7d449aef24d90b",
      "text": "NC - Not covered. Jefferies does not cover this company.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "b4ad525150db2bd0",
      "text": "Restricted - Describes issuers where, in conjunction with Jefferies engagement in certain transactions, company policy or applicable securities regulations prohibit certain types of communications, including investment recommendations.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "fc1e7ee244ac92d5",
      "text": "Monitor - Describes securities whose company fundamentals and financials are being monitored, and for which no financial projections or opinions on the investment merits of the company are provided.",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "44d535fb5d335dbb",
      "text": "Jefferies' methodology for assigning ratings may include the following: market capitalization, maturity, growth/value, volatility and expected total return over the next 12 months. The price targets are based on several methodologies, which may include, but are not restricted to, analyses of market risk, growth rate, revenue stream, discounted cash flow (DCF), EBITDA, EPS, cash flow (CF), free cash flow (FCF), EV/EBITDA, P/E, PE/growth, P/CF, P/FCF, premium (discount)/average group EV/EBITDA, premium (discount)/average group P/E, sum of the parts, net asset value, dividend returns, and return on equity (ROE) over the next 12 months.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "21cac54b7e889350",
      "text": "Jefferies Franchise Picks include stock selections from among the best stock ideas from our equity analysts over a 12 month period. Stock selection is based on fundamental analysis and may take into account other factors such as analyst conviction, differentiated analysis, a favorable risk/reward ratio and investment themes that Jefferies analysts are recommending. Jefferies Franchise Picks will include only Buy rated stocks and the number can vary depending on analyst recommendations for inclusion. Stocks will be added as new opportunities arise and removed when the reason for inclusion changes, the stock has met its desired return, if it is no longer rated Buy and/or if it triggers a stop loss. Stocks having 120 day volatility in the bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent a recommended portfolio of stocks and is not sector based, but we may note where we believe a Pick falls within an investment style such as growth or value.",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "6b2c7f74329aecda",
      "text": "Other Companies Mentioned in This Report- Arkenna SA (AKE FP: €61.30, HOLD)- Aurelia Metals Limited (AMI AU: AUD0.21, BUY)- Brenntag SE (BNR GR: €53.68, UNDERPERFORM)- Chugai (4519 JP: ¥6,568, HOLD)- Clariant AG (CLN SW: CHF8.33, HOLD)- Cohance Lifesciences Ltd (COHANCE IN: INR870.25, BUY)- Divi's Laboratories Ltd (DIVI IN: INR6,129.60, BUY)- Meta Platforms, Inc. (META: \\(\\) 751.11\\(, BUY)- Microsoft Corporation (MSFT:\\) \\ \\(509.64\\) , BUY)- Nabtesco Corp. (6268 JP: ¥3,130, HOLD)- Otsuka Corporation (4768 JP: ¥3,030, BUY)- PERSON Holdings (2181 JP: ¥278, HOLD)- Piramal Pharma Limited (PIRPHARM IN: INR186.35, BUY)- SAI Life Sciences Ltd (SAILIFE IN: INR816.55, BUY)- Snowflake Inc (SNOW: \\(\\) 241.00\\(, BUY)- Syensqo SA/NV (SYENS BB:\\) \\ \\(75.90\\) , BUY)- Symrise AG (SY1 GR: €82.68, UNDERPERFORM)- Technopro Holdings (6028 JP: ¥4,826, HOLD)- Terumo (4543 JP: ¥2,656, BUY)- Trend Micro Incorporated (4704 JP: ¥7,913, HOLD)- UACJ Corporation (5741 JP: ¥6,280, HOLD)- Ulvac (6728 JP: ¥6,051, BUY)- Umicore SA (UMI BB: €13.74, BUY)- en-japan (4849 JP: ¥1,766, HOLD)",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "d6d440c9b7c357f3",
      "text": "Distribution of Ratings",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "2e86aa802e2510d8",
      "text": "CountPercentCountPercentCountPercentBUY211160.63%37017.53%1185.59%HOLD121334.84%1058.66%221.81%UNDERPERFORM1584.54%31.90%31.90%",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "230c4a6f8de5f28c",
      "text": "Jefries does busines and seeks to do busines with companies covered in its research reports, and expects to receive or intends to seek compensation for investment banking services among other activities from such companies. As a result, investors should be aware that Jefferies may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Jefferies Equity Research refers to research reports produced by analysts employed by one of the following Jefferies Financial Group Inc. (Jefferies) companies:",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "e921ebe37be2728e",
      "text": "United States: Jefferies LLC which is an SEC registered broker- dealer and a member of FINRA (and distributed by Jefferies Research Services, LLC, an SEC registered Investment Adviser, to clients paying separately for such research).",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "cbca081d97debfb1",
      "text": "Canada: Jefferies Securities Inc., which is an investment dealer registered in each of the thirteen Canadian jurisdictions and a dealer member of the Canadian Investment Regulatory Organization, including research reports produced jointly by Jefferies Securities Inc. and another Jefferies entity (and distributed by Jefferies Securities Inc.).",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "5fda41e5b2f73933",
      "text": "Where Jefferies Securities Inc. distributes research reports produced by Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch or Jefferies India Private Limited, you are advised that each of Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch and Jefferies India Private Limited operates as a dealer in your jurisdiction under an exemption from the dealer registration requirements contained in National Instrument 31- 103 Registration Requirements, Exemptions and Ongoing Registrant Obligations and, as such, each of Jefferies LLC, Jefferies International Limited, Jefferies (Japan) Limited, Tokyo Branch and Jefferies India Private Limited is not required to be and is not a registered dealer or adviser in your jurisdiction. You are advised that where Jefferies LLC or Jefferies International Limited prepared this research report, it was not prepared in accordance with Canadian disclosure requirements relating to research reports in Canada.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "3fe39309fb957cab",
      "text": "United Kingdom: Jefferies International Limited, which is authorized and regulated by the Financial Conduct Authority, registered in England and Wales No. 1978621; registered office: 100 Bishopsgate, London EC2N 4JL; telephone +44 (0)20 7029 8000; facsimile +44 (0)20 7029 8010.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "b4a3ae84c10509f8",
      "text": "Japan: Jefferies (Japan) Limited, Tokyo Branch, which is a securities company registered by the Financial Services Agency of Japan and is a member of the Japan Securities Dealers Association; located at Tokyo Midtown Hibiya 30F Hibiya Mitsui Tower, 1- 1- 2 Yurakucho, Chiyoda- ku, Tokyo 100- 0006; telephone +813 5251 6100; facsimile +813 5251 6101.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "839c3aca1e3dc1e6",
      "text": "Australia: Jefferies (Australia) Pty Limited (ACN 623 059 898), which holds an Australian financial services license (AFSL 504712) and is located at Level 20, 60 Martin Place, Sydney NSW 2000; telephone +61 2 9364 2800.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "1124a431053d9548",
      "text": "Dubai: Jefferies International Limited, Dubai branch, which is licensed by the Dubai Financial Services Authority (DFSA Reference Number F007325); registered office Unit L31- 06, L31- 07, Level 31, ICD Brookfield Pace, DIFC, PO Box 121208, Dubai, UAE.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "321dd51deb5bbd56",
      "text": "This report was prepared by personnel who are associated with Jefferies (Jefferies Securities Inc., Jefferies International Limited, Jefferies GmbH, Jefferies Hong Kong Limited, Jefferies Singapore Limited, Jefferies (Japan) Limited, Tokyo Branch, Jefferies India Private Limited), and Jefferies (Australia) Pty Ltd; or by personnel who are associated with both Jefferies LLC and Jefferies Research Services LLC (\"JRS\"). Jefferies LLC is a US registered broker- dealer and is affiliated with JRS, which is a US registered investment adviser. JRS does not create tailored or personalized research and all research provided by JRS is impersonal. If you are paying separately for this research, it is being provided to you by JRS. Otherwise, it is being provided by Jefferies LLC. Jefferies LLC, JRS, and their affiliates are collectively referred to below as \"Jefferies\". Jefferies may seek to do business with companies covered in this research report. As a result, investors should be aware that Jefferies may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only one of many factors in making their investment decisions. Specific conflict of interest and other disclosures that are required by FINRA, the Canadian Investment Regulatory Organization and other rules are set forth in this disclosure section.",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "107189319e3c7bb2",
      "text": "If you are receiving this report from a non- US Jefferies entity, please note the following: Unless prohibited by the provisions of Regulation S of the U.S. Securities Act of 1933, as amended, this material is distributed in the United States by Jefferies LLC, which accepts responsibility for its contents in accordance with the provisions of Rule 15a- 6 under the US Securities Exchange Act of 1934, as amended. Transactions by or on behalf of any US person may only be effected through Jefferies LLC. In the United Kingdom and European Economic Area this report is issued and/or approved for distribution by Jefferies International Limited (\"JIL\") and/or Jefferies GmbH and is intended for use only by persons who have, or have been assessed as having, suitable professional experience and expertise, or by persons to whom it can be otherwise lawfully distributed. Jefferies LLC, JIL, Jefferies GmbH and their affiliates, may make a market or provide liquidity in the financial instruments referred to in this report; and where they do make a market, such activity is disclosed specifically in this report under \"company specific disclosures\".",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "d6c3f97d3dcf667f",
      "text": "For Canadian investors, this material is intended for use only by professional or institutional investors. None of the investments or investment services mentioned or described herein is available to other persons or to anyone in Canada who is not a \"permitted client\" as defined by National Instrument 31- 103 Registration Requirements, Exemptions and Ongoing Registrant Obligations, as applicable. This research report is a general discussion of the merits and",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "702576d6fc7f05b1",
      "text": "financial situation, or needs. By providing this report, neither JRS nor any other Jefferies entity accepts any authority, discretion, or control over the management of the recipient's assets. Any action taken by the recipient of this report, based on the information in the report, is at the recipient's sole judgment and risk. The recipient must perform his or her own independent review of any prospective investment. If the recipient uses the services of Jefferies LLC (or other affiliated broker- dealers), in connection with a purchase or sale of a security that is a subject of these materials, such broker- dealer may act as principal for its own accounts or as agent for another person. Only JRS is registered with the SEC as an investment adviser; and therefore neither Jefferies LLC nor any other Jefferies affiliate has any fiduciary duty in connection with distribution of these reports.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "7fdf5e1aa6bd2484",
      "text": "The price and value of the investments referred to herein and the income from them may fluctuate. Past performance is not a guide to future performance, future returns are not guaranteed, and a loss of original capital may occur. Fluctuations in exchange rates could have adverse effects on the value or price of, or income derived from, certain investments.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "ad12663d7ac633d7",
      "text": "This report may contain forward looking statements that may be affected by inaccurate assumptions or by known or unknown risks, uncertainties, and other important factors. As a result, the actual results, events, performance or achievements of the financial product may be materially different from those expressed or implied in such statements.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "3f72c14a30f8e671",
      "text": "This report has been prepared independently of any issuer of securities mentioned herein and not as agent of any issuer of securities. No Equity Research personnel have authority whatsoever to make any representations or warranty on behalf of the issuer(s). Any comments or statements made herein are those of the Jefferies entity producing this report and may differ from the views of other Jefferies entities.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "9bc13743c51057d1",
      "text": "This report may contain information obtained from third parties, including ratings from credit ratings agencies such as Standard & Poor's, and information derived from third- party or proprietary generative artificial intelligence (Gen AI) models. Jefferies does not guarantee the accuracy, completeness, timeliness or availability of this information, and is not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, or for the results obtained from the use of such content. Neither Jefferies nor any third- party content providers, including providers of Gen AI models, give any express or implied warranties, including, but not limited to, any warranties of merchantability or fitness for a particular purpose or use. Neither Jefferies nor any third- party content provider shall be liable for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs,",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "c4035c8a762475b2",
      "text": "expenses, legal fees, or losses (including lost income or profits and opportunity costs) in connection with any use of their content, including ratings. Credit ratings are statements of opinions and are not statements of fact or recommendations to purchase, hold or sell securities. They do not address the suitability of securities or the suitability of securities for investment purposes, and should not be relied on as investment advice. Reproduction and distribution of third party content in any form is prohibited except with the prior written permission of the related third party.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "cff4b482366206fe",
      "text": "Jefferies research reports are disseminated and available electronically, and, in some cases, also in printed form. Electronic research is simultaneously made available to all clients. This report or any portion hereof may not be copied, reprinted, sold, or redistributed or disclosed by the recipient or any third party, by content scraping or extraction, automated processing, or any other form or means, without the prior written consent of Jefferies. Any unauthorized use is prohibited. Neither Jefferies nor any of its respective directors, officers or employees, is responsible for guaranteeing the financial success of any investment, or accepts any liability whatsoever for any direct, indirect or consequential damages or losses arising from any use of this report or its contents. Nothing herein shall be construed to waive any liability Jefferies has under applicable U.S. federal or state securities laws.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "852c1c7fc70d531a",
      "text": "For Important Disclosure information relating to JRS, please see https://adviserinfo.sec.gov/IAPD/Content/Common/crd_iapd_Brochure.aspx? BRCHR_VRSN_ID=483878 and https://adviserinfo.sec.gov/Firm/292142 or visit our website at https://javatar.bluematrix.com/sellside/Disclosures.action, or www.jefferies.com, or call 1.888. JEFFERIES.",
      "page": 8,
      "section": null
    },
    {
      "passage_id": "82f00f9c3963eee5",
      "text": "\\(①\\) 2025 Jefferies",
      "page": 8,
      "section": null
    }
  ],
  "entities": [
    {
      "entity_id": "5cd18929612313a7",
      "name": "Arkenna SA",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "4150b24f93fc4fc2",
      "name": "As Jan",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "74bc33da7898ffa7",
      "name": "Aurelia Metals",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "8e4b2f3048fd49f0",
      "name": "Aurelia Metals Limited",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "0b02164dc6f08d3a",
      "name": "Brenntag SE",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "e92963543f0db8c2",
      "name": "But China",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "7860a2554c61a53f",
      "name": "Canadian Investment",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "995b578eab84f67e",
      "name": "China Tech",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "cbf188a1d775794a",
      "name": "Chugai Chugai",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "2e780bf99cb5b12c",
      "name": "Clariant AG",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "e823bb3627fbf301",
      "name": "Cohance Lifesciences",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "e8c692e8af4d1f04",
      "name": "Cohance Lifesciences Ltd",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "0c759b57d9ad2ce6",
      "name": "Company Specific",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "8bb7d9a681cb9e40",
      "name": "Company Valuation",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "af0350168d71efc2",
      "name": "Consumer Conference",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "4b9be408e155a05b",
      "name": "Coverage Suspended",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "e9cd18ef1469e32c",
      "name": "DFSA Reference",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "6ba4b0a762d135f4",
      "name": "Dealers Association",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "1d8b8732c5314c38",
      "name": "Disclosures\n\nJames",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "e736f0c0f1f7561e",
      "name": "Disclosures\n\nJefries",
      "type": "company",
      "aliases": []
    }
  ],
  "data": {
    "figures": [
      {
        "type": "other",
        "title": null,
        "page": 3,
        "axes": null,
        "series": [],
        "figure_id": "09e1a4d1efe02a75",
        "provenance": {
          "page": 3
        }
      }
    ],
    "tables": [],
    "numerical_data": [
      {
        "num_id": "0d4f8d01a0d2289e",
        "value": 0.11,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "arm Q2. Ulvac Ulvac announced FY6/25 results on Aug13. It reported \\(\\yen 26.5bn\\) in FY6/25 OP (- 11% YoY), roughly in line with guidance updated at 3Q timing. Ulvac officially announced the Value Up",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "e057c21ba8d3c696",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "contribution to reach guidance/consensus forecasts. We are on average \\(- 2\\%\\) below consensus (- 4% across diversifies, and - 1% in consumer chemicals), whilst consumer ingredients<｜end▁of▁sentence｜",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "04b647f4b8bf9f29",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ce/consensus forecasts. We are on average \\(- 2\\%\\) below consensus (- 4% across diversifies, and - 1% in consumer chemicals), whilst consumer ingredients<｜end▁of▁sentence｜>",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "77a92a86f551e353",
        "value": 0.15,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "loss. Stocks having 120 day volatility in the bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "ce1a254ca32cfd8c",
        "value": 0.2,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "bottom quartile of S&P stocks will continue to have a 15% stop loss, and the remainder will have a 20% stop. Franchise Picks are not intended to represent a recommended portfolio of stocks and is not ",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "ea7fcb2892675206",
        "value": 61.3,
        "unit": "€",
        "metric_type": "currency",
        "context": "r Companies Mentioned in This Report Other Companies Mentioned in This Report- Arkenna SA (AKE FP: €61.30, HOLD)- Aurelia Metals Limited (AMI AU: AUD0.21, BUY)- Brenntag SE (BNR GR: €53.68, UNDERPERFO",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "d1213fbad4a5d653",
        "value": 53.68,
        "unit": "€",
        "metric_type": "currency",
        "context": "enna SA (AKE FP: €61.30, HOLD)- Aurelia Metals Limited (AMI AU: AUD0.21, BUY)- Brenntag SE (BNR GR: €53.68, UNDERPERFORM)- Chugai (4519 JP: ¥6,568, HOLD)- Clariant AG (CLN SW: CHF8.33, HOLD)- Cohance ",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "d52460c2dd5311ee",
        "value": 6568.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "Metals Limited (AMI AU: AUD0.21, BUY)- Brenntag SE (BNR GR: €53.68, UNDERPERFORM)- Chugai (4519 JP: ¥6,568, HOLD)- Clariant AG (CLN SW: CHF8.33, HOLD)- Cohance Lifesciences Ltd (COHANCE IN: INR870.25,",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "33916e33f4569b6e",
        "value": 3130.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": ": \\(\\) 751.11\\(, BUY)- Microsoft Corporation (MSFT:\\) \\ \\(509.64\\) , BUY)- Nabtesco Corp. (6268 JP: ¥3,130, HOLD)- Otsuka Corporation (4768 JP: ¥3,030, BUY)- PERSON Holdings (2181 JP: ¥278, HOLD)- Pir",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "873da1cca6754d2d",
        "value": 3030.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "(MSFT:\\) \\ \\(509.64\\) , BUY)- Nabtesco Corp. (6268 JP: ¥3,130, HOLD)- Otsuka Corporation (4768 JP: ¥3,030, BUY)- PERSON Holdings (2181 JP: ¥278, HOLD)- Piramal Pharma Limited (PIRPHARM IN: INR186.35, ",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "f726dca8592ef9df",
        "value": 278.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "Corp. (6268 JP: ¥3,130, HOLD)- Otsuka Corporation (4768 JP: ¥3,030, BUY)- PERSON Holdings (2181 JP: ¥278, HOLD)- Piramal Pharma Limited (PIRPHARM IN: INR186.35, BUY)- SAI Life Sciences Ltd (SAILIFE IN",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "e672186edab08849",
        "value": 82.68,
        "unit": "€",
        "metric_type": "currency",
        "context": "Inc (SNOW: \\(\\) 241.00\\(, BUY)- Syensqo SA/NV (SYENS BB:\\) \\ \\(75.90\\) , BUY)- Symrise AG (SY1 GR: €82.68, UNDERPERFORM)- Technopro Holdings (6028 JP: ¥4,826, HOLD)- Terumo (4543 JP: ¥2,656, BUY)- Tre",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "494541c8d23c2320",
        "value": 4826.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "S BB:\\) \\ \\(75.90\\) , BUY)- Symrise AG (SY1 GR: €82.68, UNDERPERFORM)- Technopro Holdings (6028 JP: ¥4,826, HOLD)- Terumo (4543 JP: ¥2,656, BUY)- Trend Micro Incorporated (4704 JP: ¥7,913, HOLD)- UACJ",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "e71c9c0dc859b265",
        "value": 2656.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "ise AG (SY1 GR: €82.68, UNDERPERFORM)- Technopro Holdings (6028 JP: ¥4,826, HOLD)- Terumo (4543 JP: ¥2,656, BUY)- Trend Micro Incorporated (4704 JP: ¥7,913, HOLD)- UACJ Corporation (5741 JP: ¥6,280, H",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "80ae7f61ca21f5a5",
        "value": 7913.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "Holdings (6028 JP: ¥4,826, HOLD)- Terumo (4543 JP: ¥2,656, BUY)- Trend Micro Incorporated (4704 JP: ¥7,913, HOLD)- UACJ Corporation (5741 JP: ¥6,280, HOLD)- Ulvac (6728 JP: ¥6,051, BUY)- Umicore SA (U",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "3adcddeedd75c125",
        "value": 6280.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "4543 JP: ¥2,656, BUY)- Trend Micro Incorporated (4704 JP: ¥7,913, HOLD)- UACJ Corporation (5741 JP: ¥6,280, HOLD)- Ulvac (6728 JP: ¥6,051, BUY)- Umicore SA (UMI BB: €13.74, BUY)- en-japan (4849 JP: ¥1",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "c455067593ca7834",
        "value": 6051.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": "cro Incorporated (4704 JP: ¥7,913, HOLD)- UACJ Corporation (5741 JP: ¥6,280, HOLD)- Ulvac (6728 JP: ¥6,051, BUY)- Umicore SA (UMI BB: €13.74, BUY)- en-japan (4849 JP: ¥1,766, HOLD)<｜end▁of▁sentence｜>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "2520449aa68b5b84",
        "value": 13.74,
        "unit": "€",
        "metric_type": "currency",
        "context": "HOLD)- UACJ Corporation (5741 JP: ¥6,280, HOLD)- Ulvac (6728 JP: ¥6,051, BUY)- Umicore SA (UMI BB: €13.74, BUY)- en-japan (4849 JP: ¥1,766, HOLD)<｜end▁of▁sentence｜>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "af5c400769a9b277",
        "value": 1766.0,
        "unit": "¥",
        "metric_type": "currency",
        "context": ": ¥6,280, HOLD)- Ulvac (6728 JP: ¥6,051, BUY)- Umicore SA (UMI BB: €13.74, BUY)- en-japan (4849 JP: ¥1,766, HOLD)<｜end▁of▁sentence｜>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "93dc3c41d4ebf216",
        "value": 0.6063000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>Count</td><td>Percent</td><td>Count</td><td>Percent</td></tr><tr><td>BUY</td><td>2111</td><td>60.63%</td><td>370</td><td>17.53%</td><td>118</td><td>5.59%</td></tr><tr><td>HOLD</td><td>1213</td><",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "2a2d7ab17d479e07",
        "value": 0.1753,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>Count</td><td>Percent</td></tr><tr><td>BUY</td><td>2111</td><td>60.63%</td><td>370</td><td>17.53%</td><td>118</td><td>5.59%</td></tr><tr><td>HOLD</td><td>1213</td><td>34.84%</td><td>105</td><",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "eaeea98adbb49620",
        "value": 0.0559,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ent</td></tr><tr><td>BUY</td><td>2111</td><td>60.63%</td><td>370</td><td>17.53%</td><td>118</td><td>5.59%</td></tr><tr><td>HOLD</td><td>1213</td><td>34.84%</td><td>105</td><td>8.66%</td><td>22</td><td",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "b3bae4354ae95a9c",
        "value": 0.34840000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "63%</td><td>370</td><td>17.53%</td><td>118</td><td>5.59%</td></tr><tr><td>HOLD</td><td>1213</td><td>34.84%</td><td>105</td><td>8.66%</td><td>22</td><td>1.81%</td></tr><tr><td>UNDERPERFORM</td><td>158<",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "3d985d83f549df5b",
        "value": 0.0866,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "53%</td><td>118</td><td>5.59%</td></tr><tr><td>HOLD</td><td>1213</td><td>34.84%</td><td>105</td><td>8.66%</td><td>22</td><td>1.81%</td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "f7b6a687f0620432",
        "value": 0.0181,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ".59%</td></tr><tr><td>HOLD</td><td>1213</td><td>34.84%</td><td>105</td><td>8.66%</td><td>22</td><td>1.81%</td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><td>3</td>",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "810639dd7e0f712f",
        "value": 0.0454,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>105</td><td>8.66%</td><td>22</td><td>1.81%</td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><td>3</td><td>1.90%</td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "dae0d60dceaad2ff",
        "value": 0.019,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>22</td><td>1.81%</td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><td>3</td><td>1.90%</td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 5
        }
      },
      {
        "num_id": "8fc1a92bf3046733",
        "value": 0.019,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td></tr><tr><td>UNDERPERFORM</td><td>158</td><td>4.54%</td><td>3</td><td>1.90%</td><td>3</td><td>1.90%</td></tr></table><｜end▁of▁sentence｜>",
        "provenance": {
          "page": 5
        }
      }
    ],
    "claims": [],
    "relations": [],
    "extraction_summary": {
      "figures_count": 1,
      "tables_count": 0,
      "numerical_data_count": 28,
      "passages_count": 65,
      "entities_count": 20
    }
  }
}